Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
As off-label use continues to expand, particularly among patients with obesity or insulin resistance, our findings suggest GLP-1based therapies may warrant consideration as an adjunct to insulin in carefully selected patients. Advertisement Advertisement New service for patients with diabetes will make annual screening more convenient Association revises criteria for the diagnosis and resolution of severe conditions What to consider in the management of euglycemic DKA Less than 50% of patients with diabetes get appropriate ophthalmic screening through primary care referrals Familiarity will enhance its accessibility for patients with diabetes New study counters earlier findings linking drugs with eye disease Study highlights the value of quantitative ultra-widefield angiography Longevity in healthcare, personal experiences may provide caregivers with false sense of confidence
The introduction of new bacterial colonies triggers mild inflammatory responses in the gut lining as your immune system assesses these new inhabitants
In females, no significant effect on body weight, composition or energy balance was observed following 6 mo of L2-Cmu treatment (Supplementary Fig
Acta 102 PochiniL.ScaliseM.IndiveriC
US$ 25.76
US$ 26.92
US$ 27.56
US$ 21.24
